IREDA extends CMD additional charge to Dr. Mohanty for 3 months
- IREDA extended Dr. Bijay Kumar Mohanty's additional CMD charge for 3 months
- Extension effective from October 1, 2026, approved by Cabinet Committee
- Valid until regular incumbent appointment or further orders
- Dr. Mohanty continues as Director (Finance) during this period

*this image is generated using AI for illustrative purposes only.
IREDA extended the additional charge of Chairman and Managing Director (CMD) to Dr. Bijay Kumar Mohanty for a further period of 3 months effective October 1, 2026.
The extension was approved by the Appointments Committee of the Cabinet via an order from the Ministry of New and Renewable Energy. The directive is valid until the appointment of a regular incumbent or until further orders, whichever occurs earliest.
Governance update details
Dr. Mohanty currently serves as Director (Finance) at IREDA. This extension follows an earlier entrustment of the additional charge communicated in July 2026. The company informed stock exchanges under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
| Detail | Information |
|---|---|
| Executive | Dr. Bijay Kumar Mohanty |
| Current Role | Director (Finance) |
| Additional Charge | Chairman and Managing Director |
| Effective Date | October 1, 2026 |
| Duration | 3 months or till regular appointment |
Historical Stock Returns for IREDA
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.61% | 0.0% | -5.14% | +1.85% | -25.35% | +85.00% |
What specific strategic initiatives or policy shifts is IREDA likely to prioritize under Dr. Mohanty's continued leadership in the short term?
How might the prolonged interim leadership at IREDA influence investor confidence and stock volatility ahead of the next quarterly earnings report?
Are there any pending regulatory approvals or major renewable energy financing deals that could face delays due to the lack of a permanent CMD?


































